BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16640741)

  • 1. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus.
    Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ
    Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
    Tso TK; Huang WN; Huang HY; Chang CK
    Rheumatology (Oxford); 2006 Sep; 45(9):1148-53. PubMed ID: 16527878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors.
    Asanuma Y; Chung CP; Oeser A; Shintani A; Stanley E; Raggi P; Stein CM
    J Rheumatol; 2006 Mar; 33(3):539-45. PubMed ID: 16463434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
    Manzi S; Selzer F; Sutton-Tyrrell K; Fitzgerald SG; Rairie JE; Tracy RP; Kuller LH
    Arthritis Rheum; 1999 Jan; 42(1):51-60. PubMed ID: 9920014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is related with oxidative stress in systemic lupus erythematosus.
    Koca SS; Karaca I; Yavuzkir MF; Dağli N; Ozgen M; Ustündağ B; Işik A
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):23-8. PubMed ID: 19196569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.
    Soep JB; Mietus-Snyder M; Malloy MJ; Witztum JL; von Scheven E
    Arthritis Rheum; 2004 Jun; 51(3):451-7. PubMed ID: 15188333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
    Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
    Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
    Bruce IN; Urowitz MB; Gladman DD; Ibañez D; Steiner G
    Arthritis Rheum; 2003 Nov; 48(11):3159-67. PubMed ID: 14613278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
    Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
    Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.
    de Leeuw K; Graaff R; de Vries R; Dullaart RP; Smit AJ; Kallenberg CG; Bijl M
    Rheumatology (Oxford); 2007 Oct; 46(10):1551-6. PubMed ID: 17848401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.
    Kiss E; Soltesz P; Der H; Kocsis Z; Tarr T; Bhattoa H; Shoenfeld Y; Szegedi G
    J Autoimmun; 2006 Dec; 27(4):211-7. PubMed ID: 17088047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in systemic lupus erythematosus--evidence of increased oxidative stress and dyslipidaemia.
    Nuttall SL; Heaton S; Piper MK; Martin U; Gordon C
    Rheumatology (Oxford); 2003 Jun; 42(6):758-62. PubMed ID: 12730535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.